Jang IJ - Search Results

1

Effect of peritoneal dialysis on plasma and peritoneal fluid concentrations of isoniazid, pyrazinamide, and rifampin.

Ahn C, Oh KH, Kim K, Lee KY, Lee JG, Oh MD, Kim Y, Han JS, Kim S, Lee JS, Jang IJ, Shin SG. Ahn C, et al. Among authors: jang ij. Perit Dial Int. 2003 Jul-Aug;23(4):362-7. Perit Dial Int. 2003. PMID: 12968844

2

Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19.

Cho JY, Yu KS, Jang IJ, Yang BH, Shin SG, Yim DS. Cho JY, et al. Among authors: jang ij. Br J Clin Pharmacol. 2002 Apr;53(4):393-7. doi: 10.1046/j.1365-2125.2002.01366.x. Br J Clin Pharmacol. 2002. PMID: 11966672 Free PMC article. Clinical Trial.

3

Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects.

Kim MK, Cho JY, Lim HS, Hong KS, Chung JY, Bae KS, Oh DS, Shin SG, Lee SH, Lee DH, Min B, Jang IJ. Kim MK, et al. Among authors: jang ij. Eur J Clin Pharmacol. 2003 Jun;59(2):111-6. doi: 10.1007/s00228-003-0595-1. Epub 2003 May 1. Eur J Clin Pharmacol. 2003. PMID: 12728290

4

Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.

Yu KS, Bae KS, Shon JH, Cho JY, Yi SY, Chung JY, Lim HS, Jang IJ, Shin SG, Song KS, Moon BS. Yu KS, et al. Among authors: jang ij. J Clin Pharmacol. 2004 Jan;44(1):73-82. doi: 10.1177/0091270003261321. J Clin Pharmacol. 2004. PMID: 14681344 Clinical Trial.

5

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states.

Yu KS, Cho JY, Jang IJ, Hong KS, Chung JY, Kim JR, Lim HS, Oh DS, Yi SY, Liu KH, Shin JG, Shin SG. Yu KS, et al. Among authors: jang ij. Clin Pharmacol Ther. 2004 Aug;76(2):104-12. doi: 10.1016/j.clpt.2004.03.009. Clin Pharmacol Ther. 2004. PMID: 15289787

6

Haplotype structure and allele frequencies of CYP2B6 in a Korean population.

Cho JY, Lim HS, Chung JY, Yu KS, Kim JR, Shin SG, Jang IJ. Cho JY, et al. Among authors: jang ij. Drug Metab Dispos. 2004 Dec;32(12):1341-4. doi: 10.1124/dmd.104.001107. Epub 2004 Sep 21. Drug Metab Dispos. 2004. PMID: 15383491

7

A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.

Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ, Shin SG. Yi SY, et al. Among authors: jang ij. Clin Pharmacol Ther. 2004 Nov;76(5):418-27. doi: 10.1016/j.clpt.2004.08.002. Clin Pharmacol Ther. 2004. PMID: 15536457

8

Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers.

Chung JY, Cho JY, Yu KS, Kim JR, Jung HR, Lim KS, Jang IJ, Shin SG. Chung JY, et al. Among authors: jang ij. Clin Pharmacol Ther. 2005 Jun;77(6):486-94. doi: 10.1016/j.clpt.2005.02.006. Clin Pharmacol Ther. 2005. PMID: 15961980

9

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

Chung JY, Cho JY, Yu KS, Kim JR, Oh DS, Jung HR, Lim KS, Moon KH, Shin SG, Jang IJ. Chung JY, et al. Among authors: jang ij. Clin Pharmacol Ther. 2005 Oct;78(4):342-50. doi: 10.1016/j.clpt.2005.07.003. Clin Pharmacol Ther. 2005. PMID: 16198653 Clinical Trial.

10

Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study.

Kim E, Yu KS, Cho JY, Shin YW, Yoo SY, Kim YY, Jang IJ, Shin SG, Kwon JS. Kim E, et al. Among authors: jang ij. Hum Psychopharmacol. 2006 Dec;21(8):519-28. doi: 10.1002/hup.806. Hum Psychopharmacol. 2006. PMID: 16981227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters